Benzinga's Top Initiations

Analysts at SunTrust Robinson Humphrey initiated coverage on

with a Neutral rating. The target price for Regeneron Pharmaceuticals is set to $450. Regeneron Pharmaceuticals shares closed at $407.81 on Wednesday. KeyBanc initiated coverage on

with a Sector Weight rating. Saia shares closed at $26.66 on Wednesday. Analysts at Numis Securities initiated coverage on

with a Sell rating. GW Pharmaceuticals shares closed at $40.97 on Wednesday. Analysts at B. Riley initiated coverage of

with a Buy rating. The target price for Intralinks Holdings is set to $14.25. Intralinks Holdings shares closed at $7.79 on Wednesday. Analysts at Berenberg initiated coverage on

with a Hold rating. The target price for eBay is set to $9. Alcoa shares closed at $9.63 on Wednesday. Analysts at Citigroup initiated coverage on

with a Buy rating. The target price for Ardelyx is set to $15. Ardelyx shares closed at $10.54 on Wednesday. Analysts at H.C. Wainwright initiated coverage on

with a Buy rating. The target price for Ligand Pharmaceuticals is set to $146. Ligand Pharmaceuticals shares closed at $97.54 on Wednesday. Raymond James initiated coverage on

with a Strong Buy rating. The target price for RPC is set to $17. RPC shares closed at $14.16 on Wednesday. Guggenheim Securities initiated coverage on

with a Buy rating. The target price for Seres Therapeutics is set to $41. Seres Therapeutics shares closed at $26.73 on Wednesday. SunTrust Robinson Humphrey initiated coverage of

with a Neutral rating. The target price for Seattle Genetics is set to $34. Seattle Genetics shares closed at $32.46 on Wednesday.